Intellia Therapeutics Inc.

In News

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

GlobeNewswire - Dec 05, 2025

Intellia Therapeutics: Critical Safety Updates Are Imminent - Expect Volatility (NTLA) - Seeking Alpha

Seeking Alpha - Dec 02, 2025

Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates - Intellia Therapeutics

Intellia Therapeutics - Nov 06, 2025

Schroder Investment Management Group Increases Stock Holdings in Intellia Therapeutics, Inc. $NTLA - MarketBeat

MarketBeat - Dec 06, 2025

Intellia Therapeutics, Inc. (NTLA): A Bear Case Theory - Insider Monkey

Insider Monkey - Dec 04, 2025

Will Intellia Therapeutics Inc. (38I) stock benefit from mergers - July 2025 Momentum & Weekly Stock Performance Updates - Newser

Newser - Dec 05, 2025

Intellia Therapeutics (NASDAQ: NTLA) issues 12,600 inducement RSUs to three new employees - Stock Titan

Stock Titan - Dec 05, 2025

Intellia Therapeutics (NTLA) Downgraded After Safety Concerns and Regulatory Delays Slow Gene-Editing Progress - Yahoo Finance

Yahoo Finance - Nov 25, 2025

Intellia Therapeutics Stock (NTLA) Opinions on Clinical Trial Suspension - Quiver Quantitative

Quiver Quantitative - Nov 18, 2025

For Intellia Therapeutics, CRISPR drug’s safety concern is an existential threat - statnews.com

statnews.com - Oct 27, 2025

Intellia Therapeutics Presents Positive Longer-Term Phase 1 Data of Nexiguran Ziclumeran (nex-z) in Patients with Transthyretin (ATTR) Amyloidosis with Cardiomyopathy - Intellia Therapeutics

Intellia Therapeutics - Nov 10, 2025

Will Intellia Therapeutics Inc. (38I) stock recover faster than industry - Market Volume Summary & Technical Pattern Alert System - Newser

Newser - Dec 05, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment